Unibest

Featured Product

Upadacitinib key intermediates and API

Oral selective JAK1 — take intermediates, API, or both. Scale from R&D quantities to commercial supply, with impurity control and project-ready files.

  • JAK1
  • Once-daily oral
  • Key intermediates
  • API
01Scale

Key intermediates

Building blocks from R&D quantities through commercial scale.

  • R&D through commercial quantities
  • Scoped to the grade and volume you name
02Quality

Active pharmaceutical ingredient

API development supported by consistent quality and impurity control.

  • Robust manufacturing and analytical controls
  • Specs, COAs, methods and impurity data by project

Originator program — not a Unibest branded product

JAK0

Oral selective inhibitor (originator brand: Rinvoq)

Industry context

Upadacitinib is an oral, selective JAK1 inhibitor with proven value across immune-mediated inflammatory disease — rheumatoid arthritis, atopic dermatitis, ulcerative colitis and Crohn’s disease. Once-daily extended-release tablets are more convenient than injectable biologics. Multiple indications and long-term treatment demand make it a promising generic pipeline target — which is why key intermediates and API need a commercial-ready supply, not a research-only catalogue.

For manufacturers and marketers

01

Marketing-authorisation holders

02

Regional manufacturers

03

Distributors

Not a consumer offer, and not originator-branded product.

Why this supply

Reliable scale, consistent impurity control, and files that match the project.

01

Reliable, scalable supply

Key intermediates are available from R&D quantities through commercial scale.

02

Consistent quality and impurity control

Robust manufacturing and analytical controls support reliable API development.

03

Flexible technical support

Specifications, COAs, analytical methods and impurity information are available according to project needs.

How a program starts

Same sequence whether you take intermediates, API, or both.

  1. 01

    Scope

    Grade, volume and whether you need intermediates, API, or both. We confirm what we can stand behind before work starts.

  2. 02

    Align the file

    Specification, CoA format and impurity expectations — written down while gaps are still cheap to close.

  3. 03

    Qualify supply

    Lots and/or commercial API against that spec. Audit findings stay in the same program plan.

  4. 04

    Deliver and hold

    First shipment, then change control from one owner.

Frequently asked

No. This is a B2B supply of key intermediates and API for the molecule. It is not a consumer product and not offered under originator brand names, including Rinvoq.

Ready to scope a supply?

Send the grade and a volume range. We reply with what we can stand behind.